Two ongoing Phase 2 clinical trials of CPX-351 to be showcased

Published on September 4, 2009 at 12:30 AM · No Comments

Celator Pharmaceuticals today announced that Scott Jackson, chief executive officer, is scheduled to present at the Thomas Weisel Partners 2009 Healthcare Conference in Boston.

Mr. Jackson will provide a corporate overview and an update on the company's progress with two ongoing Phase 2 clinical trials of CPX-351 in newly diagnosed acute myeloid leukemia (AML) patients and first-relapse AML patients. The presentation will be given on Thursday, September 10, 2009 at 1:30pm EDT in the Blaxton Room of the Four Seasons Hotel.

Source: http://www.celatorpharma.com

eefc7508-4c43-414d-a913-0cef23327a0f|0|.0

Posted in: Drug Trial News

Tags: Cancer, Cisplatin, Colorectal Cancer, Drug Delivery, Irinotecan, Leukemia, Myeloid Leukemia

Silver as effective as leading chemotherapy drugsThe internet is awash with stories of how silver can be used to treat cancer. Now, lab tests have sh...
Pfizer receives FDA approval for XALKORI capsules to treat ALK-positive NSCLCPfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved XALKORI (c...
SuperGen initiates enrollment in first human trial of SGI-110 in MDS and AMLSuperGen, Inc. today announced that it has enrolled the first patient in its first in human study of...
Micromet second-quarter 2010 total revenues increase to $6.5 millionMicromet, Inc., a biopharmaceutical company focused on the development and commercialization of next...
Celator announces expansion of research agreement with CephalonCelator Pharmaceuticals today announced that it has expanded its research agreement with Cephalon, I...
Immunomedics initiates dosing in milatuzumab-doxorubicin conjugate Phase I/II trial for relapsed multiple myelomaImmunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat...
Possible biomarker for colon cancer in people under 50An abnormality of chromosomes long associated with diseases of aging has, for the first time, been l...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.